Opportunities

Hazardous Drug Compounding Service for the Louis A Johnson VA Medical Center

Special Notice from Veterans Affairs, Department of, solicitation 36C24527P0090. Responses due Nov 24, 2026. NAICS 621610. Listed on SAM.gov.

Solicitation
36C24527P0090
Notice type
Special Notice
Department
Veterans Affairs, Department of
Agency
Veterans Affairs, Department of
Office
245-network Contract Office 5 (36c245)
Posted
Nov 17, 2026
Responses due
Nov 24, 2026
Product/service code
Q517
Listed on
SAM.gov

Description

DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) Acquisition Plan Action ID: 36C245-27-AP-1021 Contracting Activity: Department of Veterans Affairs, VISN 05, NC05, Louis A Johnson VA Medical Center 1 Medical Center Drive Clarksburg, WV 26301 PR# 540-27-1-036-0349 Nature and/or Description of the Action Being Approved: The Louis A Johnson VA Medical Center Pharmacy IV room remains out of service due to ongoing flood remediation and displacement of essential compounding operations. This disruption has left our facility unable to compound hazardous medications needed for Oncology patients, placing timely access to prescribed treatments at risk. A new contract with an external provider to compound and ship these medications to the facility is essential to maintain continuity of care, prevent treatment delays, and sustain Oncology services in the interim of the compounding capabilities being restored. Due to the nature of services, there exists an unusual and compelling urgent need for this highly specialized service. The medical center requires the use of contractor due to the medical center s IV compounding room being down due to flood remediation, upgrades and recertification of the IV room and pharmacists/techs when re-opened. Existing contractual funding has been exhausted, and immediate contractual action is required to ensure continuity of these critical Oncology support services pending award of the follow-on procurement. The estimated value is $500,000.00. Description of Supplies/Services Required to Meet the Agency s Needs: The Clarksburg VA Medical Center requires emergency contract support to compound and ship hazardous medications for oncology patients. Flood remediation has displaced essential pharmacy operations and made the Pharmacy IV room unavailable, preventing on-site preparation. The contractor shall provide all chemotherapy agents, IV tubing, closed-system drug-transfer devices, and other necessary supplies. All hazardous chemotherapy agents shall be aseptically compounded according to patient-specific orders. The Medical Center can identify treatment needs including patient volume and treatment duration only one week in advance. Each week, the Clinical Pharmacy Practitioner will email the contractor a list of medications to be compounded and shipped to the Medical Center for patient treatment. Statutory Authority Permitting Other than Full and Open Competition: ( ) (1) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by RFO 6.103-1; (X ) (2) Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by RFO 6.103-2; ( ) (3) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services per 41 USC §3304(a)(3) as implemented by RFO 6.103-3; ( ) (4) International Agreement per 41 USC §3304(a)(4) as implemented by RFO 6.103-4 ( ) (5) Authorized or Required by Statute per 41 USC §3304(a)(5) as implemented by RFO 6.103-5; ( ) (6) National Security per 41 USC §3304(a)(6) as implemented by RFO 6.103-6; ( ) (7) Public Interest per 41 USC §3304(a)(7) as implemented by RFO 6.103-7; Demonstration that the Contractor s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): Optum Infusion Services 308 LLC (Optum), is the only one source that is reasonably available because of urgency and who has agreed to continue to provide this highly specialized (hazardous drug compounding) supplies/services for our Oncology patients to ensure there are no unacceptable delays in patient care. Optum maintains sterile compounding operations compliant with applicable regulatory standards, including USP 797 and USP 800, and is capable of providing patient-specific hazardous chemotherapy compounding consistent with the Statement of Work applicable to Louis A Johnson VA Medical Center. Hazardous oncology treatments are clinically time-sensitive, and a transition to an alternate provider would require onboarding and validation activities that may pose a risk of service interruption. Description of Efforts Made to ensure that offers are solicited from as many potential sources as possible (including whether a notice was or will be publicized as required by RFO Part 5 and, if not, which exception under RFO Part 5 applies): In accordance with FAR 5.202(a)(2) The proposed contract action is made under the conditions described in 6.302-2 (or, for purchases conducted using simplified acquisition procedures, if unusual and compelling urgency precludes competition to the maximum extent practicable) and the Government would be seriously injured if the agency complies with the time periods specified in 5.203. The continuing loss of in-house compounding capability creates an immediate requirement for an external provider to prepare and deliver prescribed hazardous medications within clinically required treatment timelines. Failure to establish this support as soon as possible would place oncology treatments at risk of interruption or delay. Due to flood remediation and the resulting loss of in-house hazardous-drug compounding capability, the facility requires immediate external compounding and delivery support to prevent interruption of scheduled Oncology treatments. Delays associated with conducting a full and open competitive acquisition would risk interruption of patient care and adversely affect the Medical Center's ability to provide medically necessary chemotherapy treatments. The Government determined that continuation of services through Optum represents the most immediate and least disruptive means of maintaining continuity of care while acquisition actions for the follow-on requirement are completed. …

Loading the opportunity